Novel Approach for Inborn Errors of Metabolism Screening by NMR|
Wednesday, September 04, 2013
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogeneous metabolites and 45 metabolites associated with inborn errors of metabolism.
Agilent Opens Spectroscopy Technology Innovation Center
Monday, September 02, 2013
$25 million center includes best-in-class customer demonstration and training facilities.
Bruker Announces the Appointment of Thomas Bachmann
Thursday, August 22, 2013
Appointment of Mr. Bachmann as President of the Bruker BioSpin Group.
Agilent Recognized as 2013 Laboratory Analytical Instrumentation Company of the Year in China
Tuesday, August 20, 2013
The company ranked highest in industry for leadership, growth, innovation and customer service by Frost & Sullivan.
Thomas Bachmann Appointed President of Bruker BioSpin Group
Monday, August 19, 2013
Mr. Bachmann most recently served as Chief Executive Officer of Tecan Group in Switzerland.
CEO Frederic Girard Joins Fellow Industry Experts for a QbD Round Table
Friday, August 16, 2013
New article on quality by design is now available online.
Agilent Reports Third-Quarter Results
Thursday, August 15, 2013
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Effect of Trans Fatty Acid Intake on LC-MS and NMR Plasma Profiles
Tuesday, August 13, 2013
In this study, NMR and LC-MS untargeted metabolomics has been used as an approach to explore the impact of trans fatty acid intake on plasma metabolites.
Agilent Awards Russell Varian Prize for Innovation in NMR to Dr. Lucio Frydman
Friday, August 02, 2013
His novel technique records multidimensional NMR spectra previously inaccessible via conventional NMR.